Alisertib

Puma pounces on failed Takeda drug, snapping up cancer prospect for knockdown price
Fierce Biotech
Wed, 09/21/22 - 10:17 am
Puma Biotechnology
Takeda
Aurora A/angiogenic kinase inhibitor
clinical trials
Alisertib
The top 10 biopharma pipeline disasters of 2015
Fierce Biotech
Fri, 10/30/15 - 09:55 am
Eli Lilly
GSK
AstraZeneca
Shire
Celladon
Takeda
Merck
Roche
Verastem
evacetrapib
Breo Ellipta
brodalumab
selumetinib
SHP625
Mydicar
Alisertib
suggammadex
sembragiline
Defactinib